About 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole
5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole (PubChem CID 167948403) has the molecular formula C15H18F2N4O3
and a molecular weight of 340.33 g/mol. Its IUPAC name is 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole.
Analyze 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole?
The IUPAC name of 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole (CID 167948403) is 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole.
What is the SMILES notation for 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole?
The canonical SMILES for 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole is COCC(Oc1cc(F)cc(F)c1)c1nc(N2CCNCC2)no1.
What is the InChIKey of 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole?
The InChIKey is MLTWBGWFBSXOSP-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H18F2N4O3/c1-22-9-13(23-12-7-10(16)6-11(17)8-12)14-19-15(20-24-14)21-4-2-18-3-5-21/h6-8,13,18H,2-5,9H2,1H3.
What are the key properties of 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole?
5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole has a molecular weight of 340.33 g/mol, XLogP of 1.52, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[1-(3,5-difluorophenoxy)-2-methoxyethyl]-3-piperazin-1-yl-1,2,4-oxadiazole is sourced from PubChem (CID 167948403), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).